Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide sold under names like Hygiene Pharma is a topic that causes genuine confusion online — and that confusion matters, because semaglutide is a prescription-only medicine that requires a clinical assessment before any legitimate supply. If you have come across the term "Hygiene Pharma semaglutide" while researching Wegovy or weight-loss injections in the UK, this page explains what it refers to, what it does not mean, and why the source and supply chain of your medicine is a safety question, not just a branding one. These medicines are not assessed by the MHRA for casual or cosmetic use, and a prescriber decides suitability for each individual.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most widespread misunderstanding in this space is that the active ingredient is all that counts. If it says semaglutide on the label, the thinking goes, it must work the same way and be equally safe. That is not how medicines regulation works, and it is not what the evidence from UK seizures shows.
Wegovy (the brand licensed by the MHRA for weight management) is manufactured by Novo Nordisk under pharmaceutical-grade conditions, with strict quality controls applied to sterility, dose accuracy and the stability of the formulation inside each pen. When semaglutide appears in online listings attributed to unfamiliar manufacturer names, there is no way for a consumer to verify the production standards, the actual concentration, or even whether the substance is genuine. The MHRA has been explicit on this: unlicensed weight-loss injections seized in the UK have contained incorrect doses, degraded product, and in some cases entirely wrong substances. Fake pens have caused hospitalisations.
So when you see a name like Hygiene Pharma attached to semaglutide in a search result, the first question is not the price, it is whether that product is licensed by the MHRA for supply in the UK, dispensed by a GPhC-registered pharmacy, and preceded by a genuine clinical assessment. If any of those conditions is missing, the risks are serious. The MHRA Yellow Card scheme allows anyone to report a suspect seller or product directly to the regulator.
Wegovy is a once-weekly subcutaneous injection containing semaglutide, a GLP-1 receptor agonist. GLP-1 is a gut hormone released after eating; semaglutide mimics it, signalling to the brain that you have eaten enough, slowing the rate at which the stomach empties, and reducing appetite over time. It does not burn fat directly. The effect builds gradually across the titration schedule, which a prescriber manages individually.
The NHS semaglutide medicines page describes how Wegovy is used and what to expect, it is worth reading before your consultation. Trial data from the STEP 1 study (68 weeks, published in the New England Journal of Medicine) showed an average body-weight reduction of around 15% at the 2.4mg maintenance dose alongside lifestyle changes. Those results were achieved with the licensed product, under controlled conditions, following a proper titration. They do not automatically extend to products of unknown provenance.
Wegovy is a Black Triangle medicine (▼), meaning the MHRA actively collects additional safety data on it. That is standard for newer medicines and reflects the regulator's ongoing oversight, not a reason for alarm. It does mean that reporting any side effects through Yellow Card is particularly valuable.
Many people searching for semaglutide from lesser-known manufacturers like Raw Pharma are trying to find a more affordable route to treatment. That is entirely understandable. Private weight-loss treatment carries a real cost, and the gap between listed prices from different sellers can look significant. If you want to understand how the UK market is priced and what legitimate costs include, our Wegovy cost page breaks that down honestly.
What search results for unfamiliar brand or manufacturer names rarely show you is what is absent from the listing: no GPhC-registered dispensing pharmacy, no prescriber review, no MHRA-licensed product documentation, and no recourse if something goes wrong. Sellers offering these medicines without a clinical assessment are operating outside UK law. The MHRA seized around 20 million doses of illegally traded weight-loss medicines worth approximately £45 million in 2025 alone, including the first illicit UK manufacturing site producing counterfeit tirzepatide pens, raided in Northampton in October 2025.
A practical check: any legitimate UK online pharmacy can be verified on the GPhC register in under a minute. If a seller is not listed there, that is your answer. The right metric for a prescription medicine is not the lowest price available, it is whether the supply chain is genuine, regulated and clinically overseen.
Through a regulated service like ours at nume, the route to Wegovy, whether you are based in Edinburgh or anywhere else in the UK, is straightforward and entirely transparent. You complete a free consultation; a GPhC-registered Independent Prescriber reads your answers the same day, a real clinician, not automated software. Identity is verified with photo ID, and weight is confirmed on video. If treatment is clinically appropriate, your prescription is issued and the pen is dispensed from our GPhC-registered UK pharmacy the same day if your order arrives before noon. DPD delivers it free the next working day, in plain packaging, tracked to your door.
There are no subscriptions and no auto-renewals. Every repeat order is reviewed clinically before it is approved. If you have questions about what semaglutide treatment involves, our FAQs cover the most common ones, and our team is available seven days a week. For a broader look at how semaglutide compares to other licensed weight-loss treatments, the semaglutide overview page is a useful starting point before your consultation.
If you are ready to find out whether Wegovy is clinically suitable for you, speaking to our prescribers is the next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.